IND-SWIFT LABORATORIES LIMITED

Highlights Ind-Swift Laboratories Limited

Equities

INDSWFTLAB

INE915B01019

Market Closed - NSE India S.E. Other stock markets 07:43:54 2024-07-03 EDT			5-day change	1st Jan Change
133.4 ^INR	+1.76%		+8.78%	+28.84%

06-27	Ind-Swift Laboratories Limited announced that it expects to receive funding from Essix Biosciences Limited, Hcp Investments, Zeal Global Opportunities Fund	CI
05-18	Ind-Swift Laboratories Ltd. Announces Incorporation Under Regulation 30 Regarding Incorporation of ISLL Middle East L.L.C-FZ	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Ind-Swift Laboratories Ltd. Announces Incorporation Under Regulation 30 Regarding Incorporation of ISLL Middle East L.L.C-FZ	05-18	CI
Ind-Swift Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-13	CI
Ind-Swift Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	05-13	CI
Ind-Swift Laboratories to Incorporate Wholly-Owned Arm in Dubai	04-19	MT
Ind-Swift Laboratories Limited Announces Incorporation of Wholly Owned Subsidiary	04-19	CI
Synthimed Labs Private Limited agreed to acquire API and CRAMS business of Ind-Swift Laboratories Limited and Essix Biosciences Limited.	03-17	CI
Ind-Swift Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-12	CI
Ind-Swift Laboratories Limited Collaborates with The Council of Scientific and Industrial Research	11-29	CI
Ind-Swift Laboratories Limited Reports Earnings Results for the Half Year Ended September 30, 2023	11-07	CI
Ind-Swift Laboratories Limited agreed to acquire Ind-Swift Limited.	23-09-24	CI
India's Ind-Swift Labs to sell pharma ingredients ops for $198.5 million	23-09-06	RE
Synthimed Labs Private Limited agreed to acquire API and CRAMS business of Ind-Swift Laboratories Limited for INR 16.5 billion.	23-09-05	CI
Ind-Swift Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-09	CI
Ind-Swift Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-29	CI
RN Chemicals & Pharmaceutical Private Limited acquired Halcyon life Sciences Private Limited from Ind-Swift Laboratories Limited for INR 5 million.	23-03-29	CI
Ind-Swift Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-14	CI
Ex-dividend day for final dividend	11-09-19	FA

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer